Adjuvants and malaria vaccine development.
Xiao
Lihua
L
Molecular Vaccine Section, Division of Parasitic Diseases, National Centers for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga., USA.
Rafi-Janajreh
Asimah
A
Patterson
Pamela
P
Zhou
Zhiyong
Z
Lal
Altaf A
AA
D000276:Adjuvants, Immunologic / Q000145:classification / Q000494:pharmacology; D000818:Animals; D001029:Aotus trivirgatus; D002986:Clinical Trials as Topic; D018899:CpG Islands; D016207:Cytokines / Q000502:physiology; D015195:Drug Design; D006801:Humans; D007114:Immunization / Q000379:methods; D008081:Liposomes; D008288:Malaria / Q000276:immunology / Q000517:prevention & control*; D017780:Malaria Vaccines / Q000276:immunology; D051379:Mice; D023421:Models, Animal; D010961:Plasmodium / Q000187:drug effects / Q000254:growth & development / Q000276:immunology*; D022223:Vaccines, Subunit
D000276:Adjuvants, Immunologic; D016207:Cytokines; D008081:Liposomes; D017780:Malaria Vaccines; D022223:Vaccines, Subunit